Traws Pharma, Inc. (TRAW)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Traws Pharma, Inc.. Most notable: 2026-07-09: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider purchaseOrbiMed Capital GP VIII LLC (ten_percent_owner) bought $998k of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-16 | OrbiMed Capital GP VIII LLC | ten percent owner | P | 597,729 | 1.67 | $998,207 |
| 2025-12-12 | Parker Charles Nolan | officer | A | 15,393 | 0 | $0 |
| 2025-12-12 | Leaman John Harold | director | A | 4,058 | 0 | $0 |
| 2025-12-12 | Clarke Trafford | director | A | 6,157 | 0 | $0 |
| 2025-12-12 | CAUTREELS WERNER | director | A | 4,874 | 0 | $0 |
| 2025-12-12 | Shoemaker Mary Teresa | director | A | 6,157 | 0 | $0 |
| 2025-12-12 | STOVER JACK E | director | A | 6,157 | 0 | $0 |
| 2025-12-12 | Dukes Iain D. | director | A | 36,943 | 0 | $0 |
| 2025-12-12 | Pauza Charles David | officer | A | 18,471 | 0 | $0 |
| 2025-12-12 | Redfield Robert | officer | A | 16,419 | 0 | $0 |
| 2025-12-12 | Savchuk Nikolay | director | A | 16,419 | 0 | $0 |
| 2025-04-02 | Savchuk Nikolay | officer | J | 605,531 | — | — |
| 2025-02-18 | CAUTREELS WERNER | director | M | 96,348 | 0.01 | $963 |
| 2024-04-01 | Savchuk Nikolay | director | A | 67,500 | — | — |
| 2024-04-01 | Dukes Iain D. | director | A | 67,500 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 10-Q
- 2026-08-14 8-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G
- 2026-08-12 SCHEDULE 13G/A
- 2026-07-31 8-K
- 2026-07-16 4
- 2026-07-15 4
- 2026-07-15 4
- 2026-07-14 4
- 2026-07-14 4
- 2026-07-14 4
- 2026-07-14 4
- 2026-07-14 4
- 2026-07-14 4
- 2026-07-14 4
- 2026-07-10 8-K
- 2026-07-10 424B5
- 2026-07-09 EFFECT